Alan Meds vs Primary Clinic (Direct GLP)
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alan Meds
Best for budget-conscious shoppersStarting at $99/mo
Primary Clinic (Direct GLP)
Best for Patients in the 10 covered states who want GLP-1 medications as part of a continuous Direct Primary Care relationship (including labs, routine meds, unlimited visits, and ongoing provider monitoring) rather than a transactional DTC marketplace purchase, and who calculate the $89/mo membership fee plus wholesale med cost is favorable vs $300-$500/mo all-in DTC pricing.Starting at $65/mo
Side-by-Side Comparison
| Feature | Alan Meds | Primary Clinic (Direct GLP) |
|---|---|---|
| Overall Score | 7.7/10 | ✓8.0/10 |
| Starting Price | $99/mo | ✓$65/mo |
| Editorial Rating | 3.9 ★ /5 | ✓4 ★ /5 |
| Features | 5 features | ✓10 features |
| States Available | ✓46 | 10 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alan Meds
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Primary Clinic (Direct GLP)
Pros
- ✓Direct Primary Care (DPC) model integrates GLP-1 with continuous primary care — fundamentally different from DTC marketplace pattern
- ✓GLP-1 medications at WHOLESALE COST with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
- ✓Unlimited primary care visits + direct text access + same-day care all bundled in $89/mo membership
- ✓Routine labs and thousands of medications included in membership (no surprise bills)
- ✓Per-dose pricing transparency for both semaglutide and tirzepatide (all 8 dose tiers listed publicly)
- ✓Verbatim 503A compounded-medication disclaimer published (no FDA-approval/brand-name confusion)
- ✓Hybrid model addresses common DTC complaint of 'no continuity of care' for GLP-1 patients
Cons
- ✗10 states only (WA/NM/AZ/UT/FL/DC/KS/OK/VA/GA) — limited national coverage vs 50-state DTC platforms
- ✗Membership required to access wholesale GLP-1 pricing — $89/mo adds to year-1 cost (~$1,068/yr fixed)
- ✗Specific 503A pharmacy partners NOT named
- ✗LegitScript certification NOT mentioned on the site
- ✗Named medical director NOT disclosed
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed
- ✗Brand-name Wegovy/Ozempic/Mounjaro/Zepbound NOT offered — compounded only
- ✗Site is fully JavaScript-rendered — limited HTML-only crawler visibility
- ✗Refund policy NOT publicly disclosed
Our Verdict
Primary Clinic (Direct GLP) edges out Alan Meds with a higher overall score of 8.0/10 and is particularly strong for Patients in the 10 covered states who want GLP-1 medications as part of a continuous Direct Primary Care relationship (including labs, routine meds, unlimited visits, and ongoing provider monitoring) rather than a transactional DTC marketplace purchase, and who calculate the $89/mo membership fee plus wholesale med cost is favorable vs $300-$500/mo all-in DTC pricing.. Alan Meds remains a solid alternative, especially if you're looking for budget-conscious shoppers.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.